ClarificationJul 1, 2026, 06:06 AM
Biodexa Pharmaceuticals Amends 6-K to File Legal Opinion
AI Summary
Biodexa Pharmaceuticals Plc has filed an Amendment No. 1 to its Current Report on Form 6-K, which was originally filed on June 30, 2026. The sole purpose of this amendment is to include Exhibit 5.1, which is an opinion from Stephenson Harwood LLP. No other information in the original Form 6-K has been amended or updated.
Key Highlights
- Biodexa Pharmaceuticals Plc filed an Amendment No. 1 to its Form 6-K.
- The amendment was filed solely to include Exhibit 5.1.
- Exhibit 5.1 is an opinion from Stephenson Harwood LLP.
- The original Form 6-K was filed on June 30, 2026.
Price Impact
More from BDRX